Thalidomide Attenuates the Development of Fibrosis During Post-Infarction Myocardial Remodelling in Rats
- 29 November 2006
- journal article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 8 (8) , 790-796
Abstract
Background: Inflammation plays a pathogenic role in the development of heart failure (HF). The aim of this study was to examine the effect of treatment with the immunomodulating drug thalidomide in a rat model for post-myocardial infarction (MI) HF. Methods: Rats were subjected to MI by left coronary artery ligation or sham-operated. Seven days after surgical intervention rats were randomised to treatment with thalidomide or vehicle for 8 weeks. Results: Our main findings were: (i) thalidomide treatment did not affect cardiac function or the hypertrophic response, as determined by haemodynamic measurements and heart chamber weights, respectively. (ii) HF rats treated with thalidomide had a minor reduction in septum and relative wall thickness (p<0.05), indicating an anti-remodelling effect. (iii) Thalidomide appeared to have immunostimulatory effects on the myocardium as evident by increased MIP-1α gene expression (p<0.05). (iv) Treating HF rats with thalidomide reduced myocardial collagen content, as assessed by markedly decreased levels of hydroxyproline (~ 40% reduction; p<0.05), accompanied by lower TGF-β1 gene expression (p<0.05). Conclusion: Although thalidomide had no effect on cardiac function, our results suggest that intervention with thalidomide may have beneficial effects in post-MI HF by attenuating collagen accumulation and development of myocardial fibrosis.Keywords
This publication has 27 references indexed in Scilit:
- Effect of Thalidomide on Cardiac Remodeling in Chronic Heart FailureCirculation, 2005
- Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in ratsJournal of Hepatology, 2004
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Thalidomide as a Potent Inhibitor of Neointimal Hyperplasia After Balloon Injury in Rat Carotid ArteryArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- ThalidomideThe Lancet, 2004
- Inflammatory Mediators and the Failing HeartCirculation Research, 2002
- Thalidomide impairment of trinitrobenzene sulphonic acid‐induced colitis in the rat–role of endothelial cell‐leukocyte interactionBritish Journal of Pharmacology, 2001
- New therapies for heart failure: is thalidomide the answer?QJM: An International Journal of Medicine, 2000
- Immunomodulation by thalidomide and thalidomide analoguesAnnals of the Rheumatic Diseases, 1999
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999